← Back to Search

Back Exosuit for Back Pain

N/A
Waitlist Available
Research Sponsored by Wyss Institute at Harvard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, months (1-4)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study if a wearable back exosuit can help reduce strain and fatigue for industrial workers and prevent back injuries.

Who is the study for?
This trial is for full-time workers aged 18-65 who regularly perform tasks involving bending, lifting, or lowering objects and have a back length of over 18 inches. They must speak English, have internet access, and not be pregnant or have certain medical conditions like osteoporosis or recent severe back pain.
What is being tested?
The study tests if wearing a back exosuit at work reduces lower back pain or injury compared to those without it. Participants are randomly assigned to use the exosuit as desired during work hours while completing monthly surveys about their experience and any changes in job performance.
What are the potential side effects?
Potential side effects may include discomfort from wearing the exosuit, skin issues due to sensitivity with the suit material, possible hindrance in movement leading to reduced productivity, or reliance on the device over time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, months (1-4)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, months (1-4) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Level of work-interfering low back pain (changes over time and differences between groups)
Self-reported incidence of low back pain (changes over time and differences between groups)
Workplace reported incidence of a low back injury (differences between groups)
Secondary study objectives
Self-reported intensity of global pain (changes over time and differences between groups)
Self-reported intensity of localized body discomfort (changes over time and differences between groups)
Self-reported perception of physical fatigue and effort (changes over time and differences between groups)
+2 more
Other study objectives
Perceived intervention satisfaction, job productivity, device usability, and device adverse events (changes over time and differences between groups)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExosuitExperimental Treatment1 Intervention
Exosuit refers to a soft active back exosuit. Participants in the exosuit arm will be fitted to a personal back exosuit device. Participants will be trained on how to use the device (retrieval, donning, powering up, mode switching, and doffing). Participants will be instructed to use the device at work, emphasizing they wear it whenever it seems practical (e.g. lifting) for as long as it remains comfortable. Associates from Verve Motion will check in with exosuit participants to address comfort issues and help participants integrate the exosuit into their workday.
Group II: ControlActive Control1 Intervention
Control participants will not be assigned a back exosuit. Participants in the control group will perform workplace tasks as normal, completing study surveys at baseline and monthly for 4 months that are identical to exosuit group.

Find a Location

Who is running the clinical trial?

Liberty MutualIndustry Sponsor
1 Previous Clinical Trials
19 Total Patients Enrolled
Verve MotionUNKNOWN
Wyss Institute at Harvard UniversityLead Sponsor
5 Previous Clinical Trials
133 Total Patients Enrolled

Media Library

Exosuit Clinical Trial Eligibility Overview. Trial Name: NCT05802914 — N/A
Low Back Pain Research Study Groups: Control, Exosuit
Low Back Pain Clinical Trial 2023: Exosuit Highlights & Side Effects. Trial Name: NCT05802914 — N/A
Exosuit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05802914 — N/A
~109 spots leftby Nov 2025